Published in Health Insurance Law Weekly, December 3rd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at University of Michigan, U.S.
Report 1: A type of drug used to strengthen bones when cancer has spread there may be linked to a side effect that involves deterioration of the jaw bone, according to two new reviews of cancer literature. The condition, called osteonecrosis of the jaw, is marked by exposed bone in the jaw and can lead to infection, inflammation and pain.
While researchers do not fully understand the condition or what causes it, osteonecrosis of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.